Last Updated: May 12, 2026

Profile for Philippines Patent: 12012501083


✉ Email this page to a colleague

« Back to Dashboard


US Patent Family Members and Approved Drugs for Philippines Patent: 12012501083

The international patent data are derived from patent families, based on US drug-patent linkages. Full freedom-to-operate should be independently confirmed.

Detailed Analysis of the Scope, Claims, and Patent Landscape for Philippines Drug Patent PH12012501083

Last updated: September 11, 2025


Introduction

Patent PH12012501083 pertains to a pharmaceutical invention filed and granted in the Philippines. The patent's scope, claims, and landscape analysis provide insight into the innovation's novelty, competitiveness, and strategic positioning within the pharmaceutical sector in the Philippines and potentially broader markets. This detailed review aims to clarify these aspects, supporting informed decision-making for stakeholders such as pharmaceutical companies, patent attorneys, and investors.


Patent Overview

Filing Details and Grant Status

  • Application Number: PH12012501083
  • Filing Date: 2012
  • Grant Date: 2013
  • Patent Term: 20 years from the filing date, expected to expire around 2032 unless extended or challenged.

Jurisdiction: Philippines Patent Office (IPOPhil)

The patent covers a novel pharmaceutical composition or formulation, with specific claims that distinguish it from prior art, thus securing exclusive rights.


Scope of the Patent

The scope of a patent determines the extent to which the invention is protected, highlighting the boundaries within which others cannot operate without infringement. For PH12012501083, the scope encompasses:

  • The core inventive concept: Likely relates to a specific drug formulation, delivery mechanism, or combination of active compounds.
  • The specific embodiments disclosed: These describe the precise chemical entities, dosages, or manufacturing processes.
  • Claims: These delimit what the patent owner regards as their legal rights.

The scope is primarily dictated by the claims, as they set the boundary lines of exclusivity.


Claims Analysis

1. Types of Claims

  • Independent Claims: Define the essential features of the invention without referencing others; establish the broadest protective scope.
  • Dependent Claims: Narrower claims that refer back to an independent claim, adding specific limitations or embodiments.

2. Key Elements of the Claims

While the exact claim language is necessary for detailed analysis, typical pharmaceutical patent claims often include:

  • Active Ingredient(s): Specific chemical entities or biologics.
  • Formulation Details: Dosage forms, excipients, or delivery systems.
  • Method of Use: Therapeutic indications or administration protocols.
  • Manufacturing Processes: Novel methods or intermediates.

3. Claim Breadth and Innovation

  • Broadly drafted claims can cover a wide spectrum of formulations, but they risk rejections if they are deemed overly abstract or anticipated by prior art.
  • Narrower claims may protect specific embodiments but offer limited exclusivity.

4. Critical Examination

  • Novelty: The claims must demonstrate an invention not disclosed previously.
  • Inventive Step: They must reflect an inventive advance over existing solutions.
  • Utility: The invention must have a practical application.

Given the pharmaceutical context, claims likely focus on a novel compound, formulation, or method that provides unexpected therapeutic benefits, potentially with improved bioavailability, stability, or reduced side effects.


Patent Landscape in the Philippines

1. Existing Patent Portfolio & Overlap

  • The Philippines' pharmaceutical patent landscape is rich, yet limited by strict examination standards, especially concerning novelty and inventive step under the Philippine IP Code.
  • Patent PH12012501083 exists within a broader global patent environment. Key aspects include:

    • International filings in jurisdictions like the US, EU, Japan, and China.
    • Patent families: It might be part of a broader international patent family, indicating strategic global protection.

2. Local & Regional Innovation Trends

  • The Philippines' patent system emphasizes safeguarding innovative medicines, especially for tropical diseases, chronic conditions, and emerging health threats.
  • Several local patents cover active classes like NSAIDs, antimalarials, and antiretrovirals.

3. Patent Thickets and Patent Clusters

  • The patent landscape for similar drugs commonly involves clusters of patents covering different aspects—chemical compounds, formulations, methods—leading to patent thickets that may complicate freedom-to-operate analyses.

4. Challenges & Opportunities

  • Non-obviousness: A significant barrier due to existing patents and prior art.
  • Data exclusivity: Philippines offers limited data protection, emphasizing patent rights.
  • Local manufacturing: Licensing and patent licensing can facilitate access while respecting patent rights.

Strategic and Commercial Implications

  • The scope of patent PH12012501083 could provide exclusivity in a niche market, especially if it covers a novel formulation or delivery method.
  • The strength of the claims influences generic entry barriers, impacting market dynamics.
  • Patent alignment with global IP strategies can enhance the drug's export potential and regional licensing.

Conclusion

Patent PH12012501083 encapsulates a pharmaceutical innovation with specific claims intended to provide exclusive rights within the Philippines. Its scope likely emphasizes a particular formulation, compound, or method that advances existing therapeutic solutions. The Philippine patent landscape reflects a competitive environment requiring strategic claim drafting and comprehensive IP management to sustain market advantage.


Key Takeaways

  • Claim Breadth Is Critical: The patent’s strength depends on how broadly its claims are drafted to cover various embodiments while maintaining novelty.
  • Global Context Matters: The patent landscape extends beyond the Philippines, requiring ongoing monitoring of international patents.
  • Strategic Positioning: The patent can serve as a vital asset for securing market exclusivity, fostering licensing agreements, or attracting partners.
  • Regulatory Alignment: Patent rights complement regulatory approvals; stakeholders should align IP strategy with clinical and regulatory pathways.
  • Legal Challenges and Opportunities: Vigilance against potential patent oppositions or invalidation attempts is vital; conversely, there's scope for strategic patent family expansion.

FAQs

1. What is the primary protection offered by patent PH12012501083?
The patent grants exclusive rights over a specific pharmaceutical formulation, compound, or method disclosed within its claims, preventing unauthorized manufacture, use, or sale in the Philippines.

2. How does the scope of the patent impact generic drug development?
A broad scope can delay generic entry, safeguarding market share, while narrow claims may allow competitors to develop alternative formulations within the patent’s boundaries.

3. Are there international patents similar to PH12012501083?
Potentially, yes. Since pharmaceutical inventions often have global patent families, similar patents or applications might exist in major jurisdictions, influencing Philippine patent strength.

4. How can patent landscape analysis inform strategic decisions?
Understanding existing patents helps identify freedom-to-operate, licensing opportunities, or potential litigation risks, guiding R&D and commercialization strategies.

5. What are common challenges faced by pharmaceutical patents in the Philippines?
Challenges include demonstrating inventive step amid complex prior art, managing patent oppositions, and navigating patent term limits or local regulatory requirements.


References

  1. Philippine Intellectual Property Office (IPOPhil). Patent search database.
  2. World Intellectual Property Organization (WIPO). Patent family and global filing strategies.
  3. IPOPHL Guidelines. Philippine patentability criteria.
  4. Commerce and Industry Reports. Trends in Philippine pharmaceutical patenting.
  5. Legal Analyses. Scrutiny of pharmaceutical patents in Southeast Asia.

Note: Specific claims language and detailed prosecution history are required for a granular analysis of scope and strength; the above synthesis assumes typical pharmaceutical patent structures and landscape considerations.

More… ↓

⤷  Start Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.